| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.53▼ | 9.53▼ | 9.53▼ | 9.26▼ | 9.71▼ |
| MA10 | 9.22▼ | 9.22▼ | 9.22▼ | 9.09▼ | 9.61▼ |
| MA20 | 9.46▼ | 9.48▼ | 9.53▼ | 9.63▼ | 8.97▼ |
| MA50 | 10.94▼ | 11.12▼ | 11.10▼ | 9.92▼ | 8.72▼ |
| MA100 | 10.71▼ | 10.17▼ | 9.86▼ | 9.01▼ | 12.01▼ |
| MA200 | 9.38▼ | 8.74▲ | 8.46▲ | 8.48▼ | 22.70▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.083▲ | 0.084▲ | 0.065▲ | -0.125▼ | -0.003▼ |
| RSI | 40.483▼ | 41.144▼ | 41.520▼ | 38.805▼ | 45.590▼ |
| STOCH | 64.007 | 64.007 | 61.034 | 35.302 | 29.396 |
| WILL %R | -71.711 | -71.711 | -71.711 | -91.372▼ | -92.864▼ |
| CCI | -50.768 | -50.768 | -51.408 | -147.812▼ | -49.887 |
|
Friday, November 14, 2025 04:44 AM
Research and Development (R&D) Expenses: R&D expenses were $2.5 million for the quarter ended September 30, 2025, compared to $4.6 million for the quarter ended September 30, 2024. The decrease in R&D ...
|
|
Thursday, October 30, 2025 06:00 AM
BOSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics ...
|
|
Friday, October 17, 2025 12:00 AM
Detailed price information for Sensei Biotherapeutics Inc (SNSE-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 9.46 | 9.4985 | 7.59 | 8.005 | 22,967 |
| 13/11/25 | 9.70 | 10.03 | 8.7901 | 9.02 | 45,830 |
| 12/11/25 | 9.84 | 10.30 | 9.53 | 10.10 | 64,283 |
| 11/11/25 | 9.478 | 9.69 | 9.1806 | 9.565 | 22,251 |
| 10/11/25 | 8.98 | 9.95 | 8.98 | 9.61 | 12,576 |
| 07/11/25 | 9.00 | 9.185 | 8.98 | 9.10 | 3,869 |
| 06/11/25 | 8.99 | 9.45 | 8.87 | 9.34 | 16,243 |
| 05/11/25 | 8.68 | 8.87 | 8.60 | 8.87 | 16,610 |
| 04/11/25 | 8.60 | 8.99 | 8.60 | 8.68 | 32,715 |
| 03/11/25 | 9.15 | 9.15 | 8.57 | 8.61 | 10,195 |
|
|
||||
|
|
||||
|
|